PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1620868
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1620868
The global pharmaceutical filtration market is projected to reach USD 20.97 billion by 2029 from USD 13.31 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024 to 2029. The growth of the oral proteins and peptides market has been significantly driven by increasing R&D investment by key players for the development biopharmaceutical drugs and growing adoption of continuous manufacturing process . However, requirement of high capital investments for new production facilities are restraining market growth.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2029 |
Base Year | 2023 |
Forecast Period | 2024-2029 |
Units Considered | Value (USD) |
Segments | Product, Technique, Type, Scale of Operation, and Application |
Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
"The sterile filtration segment accounted for the largest share by type in 2023."
Sterile filtration segment accounted for largest share of the market due to increasing focus on development of advanced therapies and rising focus on biomedical research. These increasing focus on biomedical research drives the demand for sterile filtration technologies to maintain sterile conditions and prevent cross-contamination for the production and manufacturing of biopharmaceuticals. Additionally, increasing approval biologics and biosimilars is driving the need of sterile filtration. Moreover, increasing vaccine production for the treatments of several diseases such as infectious diseases is promoting the segment growth in pharmaceutical filtration market.
"The US has continued to dominate the pharmaceutical filtration market during the forecast period of 2024-2029."
The US is the world's largest biopharmaceutical market and a leader in biopharmaceutical research/investments. Driven by the growing patient population suffering from infectious disease, increasing biopharmaceuticals' importance, and the necessity of safe and high-quality products in the healthcare sector, growing investments and funding in biomedical research by government bodies and pharmaceutical & biotechnology companies. Also, a strong established presence of several market players in the region is another key factor supporting market growth. These key companies include, Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US).
Danaher Corporation (US), Merck KGaA (Germany), Sartorius AG (Germany), 3M Company (US), Repligen Corporation (US), Parker Hannifin Corporation (US), Eaton Corporation plc (Ireland), Thermo Fisher Scientific, Inc. (US), Donaldson Company, Inc. (US), Porvair PLC (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), MANN+HUMMEL (Germany), Saint-Gobain (France), STERIS plc (US), Meissner Filtration Products, Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies, LLC. (US), MMS AG (Switzerland), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company, LLC (US), Filtrox AG (Switzerland), Membrane Solutions (US).
This research report categorizes the oral proteins and peptides market by Product )Consumables (Filters (Membrane Filters, Depth Filters, Air Filter, Virus Filter, and Other Filters) and Other Consumables (Filtration Assemblies, Filter Holders, and Filtration Acccessories) and Systems (Single-Use Systems and Reuseable Systems)), by Technique (Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques), by Type (Sterile Filtration and Non-Sterile Filtration) by Application (Final Product Processing (Active Pharmaceutical Ingredient Filtration, Protein Purification, Vaccines and Antibody Processing, Formulation and Filling Solutions, and Viral Clearance), Raw Material Filtration (Media Buffer filtration, Pre-Filtration, and Bioburden Testing), Cell Separation, Water Purification, and Air Purification) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the oral proteins and peptides market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the oral proteins and peptides market.
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical filtration market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.